Oxygen Levels at Birth for Low Birth Weight Infants
(HiLo Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine the optimal oxygen level for helping preterm babies, born before 29 weeks, begin breathing immediately after birth. Preterm babies often have underdeveloped lungs and require special care to prevent brain injuries from improper oxygen levels. The trial compares two groups: one receiving 30% oxygen (low concentration) and the other 60% oxygen (high concentration) to identify which leads to better survival and health outcomes. Eligible babies are those born between 23 and 28 weeks of pregnancy, who will receive full resuscitation and have no major congenital issues. As an unphased trial, this study provides a unique opportunity to contribute to crucial research that could enhance care for future preterm infants.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that using higher oxygen levels, such as 60%, for newborns with low birth weight might not be ideal. Some studies have found increased risks, including organ damage and serious brain bleeding, associated with high oxygen use. In certain cases, a nearly fivefold higher risk of death links to higher oxygen levels.
Conversely, starting with lower oxygen levels, like 30%, does not clearly show harm or benefit compared to higher levels. This indicates that experts still lack a definite answer on the best approach.
In summary, while both oxygen levels carry risks and uncertainties, there is insufficient evidence to declare one safer than the other. This trial seeks to determine which level might be better for these tiny, early arrivals.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different oxygen levels at birth might impact low birth weight infants, which could lead to more tailored care strategies. Traditionally, standard care involves using a set oxygen level, but this study tests whether starting with 30% or 60% oxygen and adjusting based on the baby's needs can improve outcomes. By fine-tuning oxygen delivery in the crucial first minutes of life, the trial aims to optimize oxygen saturation levels, potentially reducing complications and improving long-term health for these vulnerable infants.
What evidence suggests that this trial's treatments could be effective for preterm infants?
This trial will compare the effects of different oxygen levels at birth for low birth weight infants. Research has shown that using 60% oxygen, which participants in the 60% group of this trial will receive, does not significantly change survival rates or other health outcomes compared to lower oxygen levels, such as the 30% oxygen that participants in the 30% group will receive. One study found no difference in survival or major health issues when starting with high oxygen (60%) versus low oxygen (30%) at birth. However, higher oxygen levels have been linked to a greater risk of serious brain bleeding, known as intraventricular hemorrhage (IVH), and in some cases, a much higher risk of death. Oxygen is vital for helping these infants breathe, but finding the right balance is crucial to avoid harm. Therefore, determining the best oxygen level is a key focus to improve survival and health for these vulnerable infants.12567
Who Is on the Research Team?
Georg Schmolzer
Principal Investigator
University of Alberta
Are You a Good Fit for This Trial?
This trial is for very low birthweight infants born between 23 and nearly 29 weeks of gestation, who will receive full resuscitation at the study center without major congenital abnormalities. It excludes those not born in this range, with significant birth defects, or who won't get full resuscitation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Resuscitation
Infants are resuscitated with either 30% or 60% oxygen concentration for the first 5 minutes after birth, followed by oxygen titration for stability
Neonatal Intensive Care
Infants are monitored and treated in the Neonatal Intensive Care Unit (NICU) for complications and stabilization
Follow-up
Participants are monitored for neurodevelopmental outcomes and mortality
What Are the Treatments Tested in This Trial?
Interventions
- 30% oxygen group
- 60% oxygen group
30% oxygen group is already approved in Canada for the following indications:
- Resuscitation of preterm infants <29 weeks gestation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Université de Montréal
Collaborator
University of Ottawa
Collaborator
University of British Columbia
Collaborator
Memorial University of Newfoundland
Collaborator
University College Cork
Collaborator
University of Calgary
Collaborator
Laval University
Collaborator
Dalhousie University
Collaborator
University of Toronto
Collaborator